Trademarkia Logo

Canada

C$
Trademark Search in Canada
AMNUVX

View On IC.GC.CA

AMNUVX
ADVERTISED

on 16 Apr 2025

Last Applicant/ Owned by

Organogenesis Inc.

85 Dan RoadCanton MA 02021

US

Serial Number

2302396 filed on 30th Nov 2023

AMNUVX

Trademark usage description

medical preparation containing human biological material, namely, bioactive suspension derived from human amnion and amniotic fluid used in treating d Read More

Classification Information

Class [005]
Medical preparation containing human biological material, namely, bioactive suspension derived from human amnion and amniotic fluid used in treating degenerative disease of the articulating joints.

Classification kind code

12

Mark Details

Serial Number

2302396

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 16th Apr 2025		Advertised
Submitted for opposition 27
on 21st Mar 2025		Approval Notice Sent
Submitted for opposition 26
on 21st Mar 2025		Approved
Submitted for opposition 22
on 13th Mar 2025		Search Recorded
Submitted for opposition 256
on 28th Oct 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th Dec 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 28th Dec 2023		Formalized
Submitted for opposition 1
on 28th Dec 2023		Created
Submitted for opposition 228
on 30th Nov 2023		International Registration
Submitted for opposition 30
on 30th Nov 2023		Filed